Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
2018 · The Lancet Haematology · 269 citations
https://doi.org/10.1016/s2352-3026(18)30175-3
N
Nicolas Delanoy
Hôpital Européen(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
910
Citations
13
h-index
16
i10-index
Nicolas Delanoy is an academic researcher from Hôpital Européen. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Prostate Cancer Treatment and Research & Endometrial and Cervical Cancer Treatments. The author has an h-index of 13, co-authored 58 publications.
ORCID: 0000-0002-8286-7868Papers by this author
worksThe impact of the Paris terrorist attacks on the mental health of resident physicians
2019 · BMC Psychiatry · 24 citations
https://doi.org/10.1186/s12888-019-2058-y
Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials
2019 · European Journal of Cancer · 10 citations
https://doi.org/10.1016/j.ejca.2019.10.029
Identifying homogeneous healthcare use profiles and treatment sequences by combining sequence pattern mining with care trajectory clustering in kidney cancer patients on oral anticancer drugs: A case study
2022 · Health Informatics Journal · 6 citations
https://doi.org/10.1177/14604582221101526
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat